Arcus Biosciences, Inc. company logo
Arcus Biosciences, Inc. logo

Arcus Biosciences, Inc. (RCUS) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$150.00M$23.00M+18.11%

Summary

Current Value
As of today, RCUS annual cash & cash equivalents is $150.00M, up +18.11% on
Historical Performance
RCUS annual cash & cash equivalents is up +1.35% over the past 3 years, and up +158.90% over the past 5 years
All-Time High Comparison
RCUS annual cash & cash equivalents is currently -27.18% below its historical high of $206.00M set on
3-Year Low Comparison
RCUS annual cash & cash equivalents is +18.11% above its 3-year low of $127.00M reached on
Sector Comparison
RCUS annual cash & cash equivalents is higher than 72.54% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

RCUS Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$150.00M+18.1%+1.4%+158.9%+130.2%
Quarterly Cash & Cash Equivalents$831.00M-23.7%-20.8%+6.2%
Price$21.35+43.1%+15.5%-30.8%
Annual Current Assets$1.02B+22.3%-19.5%+427.2%+919.1%
Annual Total Liabilities$665.00M+5.1%-11.4%+1593.5%+6392.9%
Annual Working Capital$790.00M+22.1%-27.9%+364.7%+739.1%
Annual Net Income-$283.00M+7.8%-635.7%-234.1%-1474.8%

Cash and Cash Equivalents Highs

RCUS Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$206.00MN/A-27.2%
5Y$206.00M-27.2%
All$206.00M-27.2%

Cash and Cash Equivalents Lows

RCUS Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$127.00M+18.1%
5Y$127.00M+18.1%
All$57.94M+158.9%

Cash and Cash Equivalents History

YearValueChange
$150.00M+18.1%
$127.00M-38.3%
$206.00M+39.2%
$148.00M-14.7%
$173.42M+199.3%
YearValueChange
$57.94M-18.5%
$71.06M-27.8%
$98.43M+51.1%
$65.16M-

FAQ

  • What is the current annual cash & cash equivalents of RCUS?

    As of today, RCUS annual cash & cash equivalents is $150.00M

  • What is 1-year change in RCUS annual cash & cash equivalents?

    RCUS annual cash & cash equivalents is up +18.11% year-over-year

  • What is 3-year change in RCUS annual cash & cash equivalents?

    RCUS annual cash & cash equivalents is up +1.35% over the past 3 years

  • How far is RCUS annual cash & cash equivalents from its all-time high?

    RCUS annual cash & cash equivalents is currently -27.18% below its historical high of $206.00M set on December 31, 2022

  • How does RCUS annual cash & cash equivalents rank versus sector peers?

    RCUS annual cash & cash equivalents is higher than 72.54% of companies in Healthcare sector

  • When is RCUS next annual earnings release?

    The next annual earnings release for RCUS is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. RCUS Official Website www.arcusbio.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1724521/000172452125000116/0001724521-25-000116-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1724521/000172452125000040/0001724521-25-000040-index.htm
  4. RCUS Profile on Yahoo Finance finance.yahoo.com/quote/RCUS
  5. RCUS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rcus